Home

TIMOTHY P LYNCH

CIK 1270925 · last filed 2026-08-21

TIMOTHY P LYNCH is a corporate insider who has filed 23 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider bought $243.5K of AEON on Aug 21, 2026. Across all open-market trades the lifetime net is +$6.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions. 2 SEC filings were submitted jointly with Jon M Plexico.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.71M

Companies

7

Total Filings

23

Lifetime Open-Market Net

$6.22M

Filer Profile

Reported Address
1802 NW WILD RYE CIRCLE
BEND, OR 97703
Related Filers
Jon M Plexico — 2 joint filings, latest 2017-03-21
STONEPINE CAPITAL, L.P. — 2 joint filings, latest 2017-03-21
Stonepine Capital Management, LLC — 2 joint filings, latest 2017-03-21
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AEON 10%+ Owner 6,500,000 $0.26 $1.71M $243.5K 1 2026-08-21
VIVEVE MEDICAL, INC. (VIVE) Delisted 10%+ Owner 2,600 $0.00 $1 $6.00M 1 2016-06-21
ALLOS THERAPEUTICS INC (ALTH) Delisted Director — — — $0 5 2011-06-23
Vaxart, Inc. (NABI) Delisted Director 0 — — -$20.0K 6 2011-05-27
BIOFORM MEDICAL INC (BFRM) Delisted Director 0 — — $0 4 2010-02-19
INSITE VISION INC (ISV) Delisted Director — — — $0 1 2008-09-25
ARADIGM CORP (ARDM) Delisted Director 6,000 — — $0 3 2008-07-09

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-21 AEON Buy (P) +1,150,000 $243.5K EDGAR
2016-06-21 VIVEVE MEDICAL, INC. (VIVE) Delisted Buy (P) +1,200,000 $6.00M EDGAR
2011-06-23 ALLOS THERAPEUTICS INC (ALTH) Delisted Grant (A) — $0 EDGAR
2011-05-27 Vaxart, Inc. (NABI) Delisted Grant (A) — $0 EDGAR
2010-12-22 — Grant (A) — $0
2010-06-24 ALLOS THERAPEUTICS INC (ALTH) Delisted Grant (A) — $0 EDGAR
2010-05-24 Vaxart, Inc. (NABI) Delisted Grant (A) — $0 EDGAR
2010-02-19 BIOFORM MEDICAL INC (BFRM) Delisted Mixed −45,454 -$247.7K EDGAR
2009-12-29 BIOFORM MEDICAL INC (BFRM) Delisted Mixed +45,454 $0 EDGAR
2009-12-18 — Grant (A) — $0
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.